These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18470760)

  • 41. Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies.
    Meng Z; Quan H; Fan L; Kringle R; Sun G
    J Biopharm Stat; 2010 May; 20(3):665-82. PubMed ID: 20358444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical evaluation of QT/QTc prolongation and proarrhythmic potential for nonantiarrhythmic drugs: the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use E14 guideline.
    Darpo B; Nebout T; Sager PT
    J Clin Pharmacol; 2006 May; 46(5):498-507. PubMed ID: 16638733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance.
    Darpo B
    Br J Pharmacol; 2010 Jan; 159(1):49-57. PubMed ID: 19922536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
    Marbury TC; Jin B; Panebianco D; Murphy MG; Sun H; Evans JK; Han TH; Constanzer ML; Dru J; Shadle CR
    Anesth Analg; 2009 Aug; 109(2):418-25. PubMed ID: 19608812
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heart rate-dependence of QTc intervals assessed by different correction methods in patients with normal or prolonged repolarization.
    Chiladakis J; Kalogeropoulos A; Arvanitis P; Koutsogiannis N; Zagli F; Alexopoulos D
    Pacing Clin Electrophysiol; 2010 May; 33(5):553-60. PubMed ID: 20025715
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged QT interval corrected for heart rate during diabetic ketoacidosis in children.
    Kuppermann N; Park J; Glatter K; Marcin JP; Glaser NS
    Arch Pediatr Adolesc Med; 2008 Jun; 162(6):544-9. PubMed ID: 18524745
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heart rate dependent modification of the QTc cut-off values can improve accurate evaluation of QT prolongation.
    Sadanaga T; Sadanaga F; Yao H; Fujishima M
    Am J Cardiol; 2004 Mar; 93(6):772-5. PubMed ID: 15019891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
    Wedam EF; Bigelow GE; Johnson RE; Nuzzo PA; Haigney MC
    Arch Intern Med; 2007 Dec; 167(22):2469-75. PubMed ID: 18071169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Magnitude of error introduced by application of heart rate correction formulas to the canine QT interval.
    King A; Bailie M; Olivier NB
    Ann Noninvasive Electrocardiol; 2006 Oct; 11(4):289-98. PubMed ID: 17040276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sample size of thorough QTc clinical trial adjusted for multiple comparisons.
    Tsong Y; Sun A; Kang SH
    J Biopharm Stat; 2013; 23(1):57-72. PubMed ID: 23331221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of change in posture and exercise on repolarization in patients with long QT syndrome with HERG channel mutations.
    Walker BD; Krahn AD; Klein GJ; Skanes AC; Yee R; Wang J; Hegele RA
    Can J Cardiol; 2005 Jan; 21(1):33-8. PubMed ID: 15685300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. QT hysteresis in long-QT syndrome children with exercise testing.
    Gao DS; Fang WY; Chiu-Man C; Kirsh J; Gross G; Hamilton RM
    Chin Med J (Engl); 2007 Feb; 120(3):179-82. PubMed ID: 17355817
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utility of positive controls in assessing assay sensitivity in ICH S7B and ICH E14 guidance for evaluation of QT/QTc interval prolongation.
    Chiang AY; Mallinckrodt CH; Dmitrienko AA; Leishman DJ
    J Pharmacol Toxicol Methods; 2010; 62(2):143-7. PubMed ID: 20570744
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Onsite QTc interval screening for patients in methadone maintenance treatment.
    Fareed A; Vayalapalli S; Byrd-Sellers J; Casarella J; Drexler K; Amar R; Smith-Cox J; Lutchman TS
    J Addict Dis; 2010 Jan; 29(1):15-22. PubMed ID: 20390695
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Baseline correction in a two-way randomized blocks design.
    Overall JE; Magee KN
    J Biopharm Stat; 1992; 2(2):205-17. PubMed ID: 1300214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As.
    Rossman EI; Wisialowski TA; Vargas HM; Valentin JP; Rolf MG; Roche BM; Riley S; Pugsley MK; Nichols J; Li D; Leishman DJ; Kleiman RB; Greiter-Wilke A; Gintant GA; Engwall MJ; Delaunois A; Authier S
    J Pharmacol Toxicol Methods; 2023; 123():107270. PubMed ID: 37164235
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of electrocardiograms in clinical trials: a public discussion of the proposed ICH E14 regulatory guidance. April 11-12, 2005, Bethesda, MD, USA.
    Cavero I; Crumb W
    Expert Opin Drug Saf; 2005 Jul; 4(4):795-9. PubMed ID: 16011455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A powerful test for the maximum treatment effect in thorough QT/QTc studies.
    Deng Y; Chen F; Li Y; Qian K; Wang R; Zhou XH
    Stat Med; 2021 Apr; 40(8):1947-1959. PubMed ID: 33463746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. On the designs of thorough QT/QTc clinical trials.
    Tsong Y
    J Biopharm Stat; 2013; 23(1):43-56. PubMed ID: 23331220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The joint modeling of drug and positive control effects to estimate sample size and power in crossover "thorough" QT/QTc studies.
    Hosmane B; Locke C; Chiu YL
    J Biopharm Stat; 2013; 23(4):871-80. PubMed ID: 23786591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.